Open-label, multicenter, phase 3, extension study of the safety and efficacy of donepezil in patients with Alzheimer disease

Archives of Neurology

Volumn 58, Issue 3, 2001, Pages 427-433

  Doody, R S ^a   Geldmacher, D S ^a   Gordon, B ^a   Perdomo, C A ^a   Pratt, R D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; PLACEBO;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC DISEASE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0035103036     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.58.3.427     Document Type: Article

References (20)

1. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial
2. Metrifonate treatment of the cognitive deficits of Alzheimer's disease
3. Donepezil improves cognition and global function in Alzheimer's disease: A 15-week, double-blind, placebo-controlled study
4. A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease
5. E2020: The pharmacology of a piperidine cholinesterase inhibitor
6. 24-Week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
7. The effects of donepezil in Alzheimer's disease: Results from a multinational trial
8. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: Final analysis of a US multicentre open-label study
9. Inhibitory action of E2020, a novel acetylcholinesterase inhibitor, on cholinesterase: Comparison with other inhibitors
10. The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicenter, randomized, double-blind, placebo-controlled trial
11. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force in Alzheimer's disease
12. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician
13. A new clinical Scale for the staging of dementia
14. Declaration of Helsinki recommendations guiding physicians in biomedical research involving human subjects
15. A new rating scale for Alzheimer's disease
16. A large scale trial of donepezil in the treatment of Alzheimer's disease: Concomitant medications and the effects on heart rate
17. A large-scale, open-label trial of donepezil in the treatment of Alzheimer's disease